Mesenchymal stem cell therapy shows promise for treating MS, but more research is needed on long-term safety and efficacy, a ...
Early intervention and effective therapies are transforming multiple sclerosis management, enhancing patient outcomes, and delaying disability progression.
Scientists have identified a natural compound that halts the process involved in the progression of certain forms of cancer and demyelinating conditions — those that damage the sheath, known as myelin ...
He revealed more recently he had bio-cellular therapy treatment on his spine Kevin Winter/Getty Jack Osbourne is opening up about his Multiple Sclerosis (MS) diagnosis. The 38-year-old media ...
B-cell depletion is effective in MS and NMOSD, with anti-CD20 and anti-CD19 mAbs showing distinct mechanisms impacting safety and tolerability. Glycoengineering enhances ADCC activity, mitigating ...
Share on Pinterest A recent study reports that starting treatment at the first signs of MS symptoms could help slow disease progression. Jennifer Blount/Getty Images A recent study finds getting ...
Multiple sclerosis (MS) affects around 1.8m people worldwide. Symptoms include fatigue, blurred vision, and trouble walking. Eventually, some people become severely disabled and complications from the ...
The right multiple sclerosis (MS) treatment can slow your disease and reduce the number of attacks you get. But if you're a woman -- as 3 out of 4 people with MS are -- choosing a treatment becomes ...
VIRGINIA BEACH, Va. (WAVY) — Walk MS is two weeks away, and more than 1,500 people in the area are hard at work fundraising and building their teams. Thanks to funds raised at events like Walk MS, a ...
A type of chemotherapy drug, called mitoxantrone, can potentially treat multiple sclerosis (MS) by suppressing blood cells that attack your myelin, the protective layer covering your brain and spinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results